$FMC

FMC: Q2 2026 saw a 17% revenue drop and $186.6M net loss amid restructuring and asset sales

FMC Corporation reported Q2 2026 revenue fell 17% year over year to reflect lower volumes and pricing pressure, and it posted a $186.6M net loss. According to the company’s SEC 10-Q, restructuring charges and asset sales contributed, while a $400M equity investment is intended to strengthen the balance sheet and reduce debt.

Original reporting
Published Jul 30, 2026, 6:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 7:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FMC: Q2 2026 saw a 17% revenue drop and $186.6M net loss amid restructuring and asset sales — source image
Decision brief

The 30-second read

$FMCBearishMed
01

Why it matters

Revenue decline and a large net loss increase near-term earnings risk, while equity investment and asset sales are intended to strengthen the balance sheet and reduce debt.

02

Market read

This is a company-specific financial and capital-structure update that can drive repricing as investors assess restructuring execution and debt reduction versus ongoing demand/pricing pressure.

03

What to watch

The summary omits segment performance, guidance, and cash flow details; traders may be over-weighting the net loss without seeing whether operating cash generation is improving.

Relevance 6/10Novelty 6/10Timing: today’s SEC 10-Q summary for Q2 2026

Background

The text summarizes FMC’s Q2 2026 results from an SEC 10-Q, highlighting revenue weakness, restructuring charges, and balance-sheet actions.

Company-level read

Ticker impact

$FMCBearishMedium confidence
Context

FMC reported Q2 2026 revenue down 17% year over year and a $186.6M net loss tied to restructuring, asset sales, and a $400M equity investment.

Expected impact

Near-term downside bias is likely as traders weigh restructuring costs and weak volumes/pricing against debt reduction and capital injection.

Evidence & confidence

The article provides concrete financial deterioration (revenue decline, net loss) plus capital actions (equity investment, asset sales) that typically increase uncertainty and can pressure valuation until execution clarity improves.

Market effects

Could reinforce cautious sentiment toward chemical/agrochemical peers if restructuring and pricing pressure are industry-wide.

No specific regional demand or policy linkage provided in the text.

No explicit global macro or trade exposure details beyond general volume and pricing pressure.

Counterpoint

Asset sales plus a $400M equity investment may stabilize liquidity and reduce debt risk, which can eventually support a rebound if restructuring costs are front-loaded.

Key entities

  • FMC Corporation

    Subject of the filing summary, reporting Q2 2026 revenue decline, net loss, restructuring charges, asset sales, and a $400M equity investment.

Related articles

$FMCMedAI 8/10

FMC (FMC) Q2 2026 Earnings Call Transcript

FMC Corp. held its Q2 2026 earnings call. It reported Q1 revenue of $762 million, down 4% year over year, and adjusted EBITDA of $72 million. Full-year guidance calls for revenue of $3.6 billion to $3.8 billion and adjusted EBITDA of $670 million to $730 million. The company targets $1 billion debt reduction in 2026 via an India business sale and other disposals.

$FMCMed

Why FMC Corporation Rallied Today

Shares of FMC Corporation (FMC +18.18%) rallied on Thursday, up 15.8% as of 12:03 p.m. EDT. The agricultural chemicals company reported earnings last night. While the initial market reaction was negative due to a revenue miss and guidance cut, there was apparently enough good news to trigger a relief rally in this very beaten-down stock. ( 18.18 %) $ 1.82 $ 11.83 $1.3BMarket cap calculated using publicly traded shares outstanding only.

$FMCMedAI 8/10

FMC Corporation reports second quarter 2026 results with Adjusted EBITDA above high end of guidance range and solid cash generation

FMC Corporation (NYSE: FMC) reported Q2 2026 revenue of $867 million, down 17% year over year, and Adjusted EBITDA of $153 million. GAAP net loss was $187 million, or $1.49 per diluted share. Cash from operations rose to $363 million. FMC lowered full-year 2026 guidance, including revenue excluding India to $3.50-$3.70 billion and Adjusted EBITDA to $620-$680 million.

$FMCMedAI 8/10

FMC CORP (FMC): Results of Operations and Financial Condition

FMC CORP (FMC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 fmcex991063026.htm EX-99.1 Document Exhibit 99.1 FMC Corporation 2929 Walnut Street Philadelphia, PA 19104 USA News Release 215.299.6000 fmc.com For Release: Immediate Media contact: Nicole Canning +1.215.299.5916 Nicole.Canning@fmc.com Investor Contact: Curt Brooks + 1

$CTVAMed

Corteva stock hits all-time high at 89.46 USD By Investing.com

Corteva Inc. (CTVA) shares hit an all-time high of $89.46 and are about 0.99% below its 52-week high, up 31% YTD and 21.76% over one year. InvestingPro says the stock looks overvalued versus fair value, with P/E 47.75. Morgan Stanley reiterated Overweight with a $95 target; Corteva also announced a crop protection spinoff board and a $200 million prepurchase deal with FMC.